The amount of money a company raises to finance its operation is an important metric, but I’ve learned that entrepreneurs and investors often calculate this differently. We recently sent out our quarterly survey to the 25 investments we’ve made through the MergeLane accelerator and fund for startups with at least one woman in leadership. Case in point, 10 of our 25 portfolio companies calculated the Capital Raised to Date metric differently than I would have. This got me thinking: What should really be included in this metric?
“Capital Raised to Date” is not a standard accounting term and, to my knowledge, there is no standard definition or official guideline for calculating this metric. However, it is one of the most commonly reported metrics in the startup community, so I thought it might be helpful to try to outline a standard. After putting some thought into this, speaking with other experienced investors, and consulting our CPA firm Anton Collins Mitchell, I’ve developed the following guide for calculating this metric. Please comment if you have feedback.
What might be included in “Capital Raised to Date”?
The following is a comprehensive list of things that entrepreneurs and investors couldconceivably argue should be classified as Capital Raised to Date:
What should be included in “Capital Raised to Date”?
What should be included is another question. The answer, in my opinion, depends on the intention of the metric.
I think all of the items above would be more accurately classified as “Capital Required to Date” and should only be used if the metric is being used for the following reasons:
However, from my experience, the “Capital Raised to Date” metric is not typically used for the reasons stated above but rather for two other main reasons: 1) to understand capital efficiency, and 2) to measure the progress the company has achieved. The items that should be included are different for each.
Using “Capital Raised to Date” to measure efficiency
If the intention of the metric is to understand capital efficiency, i.e., how much capital has been required to date, I think the following should be included:
Using “Capital Raised to Date” to measure progress
If the intention of the metric is to understand the progress the company has made, i.e., company traction, outside validation (i.e., how many people have said “yes” to the business), and the stage of the business (e.g., a company that has raised $5 million is typically later in its business lifecycle than a company that has raised $500,000), then the following should be included. (Note: This is the definition we typically use when vetting potential MergeLane investments and monitoring portfolio results. If you are using this metric for MergeLane-related purposes, e.g., our quarterly survey, please use this method.)
Should revenue be included in “Capital Raised to Date”?
Revenue from company operations should not be included in this metric. This also applies to capital raised through rewards-based crowdfunding, e.g., Kickstarter campaigns. As I mentioned above, the cost of the reward received should be subtracted from the total raised.
Using “Capital Raised to Date” when the intention is unclear
If there are multiple intentions or the intention is unclear, e.g., an investor asks an entrepreneur how much money they have raised to date and doesn’t reveal his or her motivation, I think it makes sense to avoid this metric all together. It is better to list the details the person asking the question will most likely want to hear.
Under this scenario, I would not mention the following simply because I find these to be atypical things to include:
I would include the following:
Here is a suggested format:
Company X has raised $X dollars from investors. (Include all dollars invested through equity and convertible debt and mention the amount of founder investment if it is above $50,000. This shows founder commitment.) The company has also received $X in nondilutive funding grants and awards. (Include all dollars raised through awards and grants. It might make sense to break this into specifics if the grants or awards are impressive and well-known, e.g., an NSF grant.) We raised $X in nonequity crowdfunding. (Include all dollars raised through rewards-based crowdfunding, including dollars raised in exchange for something of value and mention the platform if it is recognizable, e.g., Kickstarter. Stating this total number provides validation for the business opportunity.) Company X obtained a [insert type of debt financing] for $X. (This last sentence should be used to disclose any major liabilities over $50,000 and/or enhance credibility by mentioning other people or individuals who have said “yes” to the business.)
Here is an example:
“Company X has raised $1,000,000 from investors, $100,000 of which was invested by our founders. The company has also received $250,000 of nondilutive funding from the National Science Foundation, won $100,000 from a national pitch competition, and raised $300,000 from a successful Kickstarter campaign. Company X has obtained a bank loan of $150,000 and a private loan from the founder of Uber for $50,000.”
Dilutive vs. Nondilutive Funding
As if “Capital Raised to Date” weren’t confusing enough, there is also this issue of dilutive vs. nondilutive funding.
Dilutive funding includes all capital raised in exchange for equity in the company, e.g., preferred stock. Nondilutive funding includes anything lent or donated to the company, e.g., debt financing or grants. Because the amount of equity previously awarded by a company is a very important detail, it is helpful for investors and entrepreneurs to break Capital Raised to Date into nondilutive vs. dilutive funding. However, the big question here is this: How is convertible debt classified? To my knowledge, there is no standard for this, but I feel very strongly that convertible debt should be classified as dilutive funding. The intention of convertible debt is to convert it into equity and, from my experience, it is seldom repaid to investors as debt.
There you have it. Capital Raised to Date is clear as mud. What do you think?
Elizabeth Yin, co-founder and general partner at the Hustle Fund, shared her thoughts on how to assess a startup’s ability to “hustle”. Her thoughts are applicable to venture capitalists, startups and anyone who wants to work with hustlers.
Nearly every email I receive starts with “Sorry for the delay.” Our always-on culture has set an unwritten expectation that an email should be responded to within 24 hours. To prevent the perpetuation of this cultural expectation, I would like to make my thoughts clear.
We asked our Fund81 forum for venture capitalists to nominate portfolio companies to participate in a startup showcase. We received over 50 nominations. Four of those startups are featured in this episode.
Jocelyn Goldfein from Zetta Venture Partners joined the Fund81 podcast to share her approach to investing in artificial intelligence (AI). With the cost of creating software continuing to decline, Zetta believes the companies of the future will need to build more than just great software to thrive.
I love being active, but I also have high professional aspirations. I’ve spent the last 16 years trying to find a productive balance between the two. In this episode, Nicole DeBoom, pro triathlete turned CEO of Skirt Sports, and I share our thoughts on how to fit fitness into a startup schedule.
Fundraising doesn’t come naturally to David Cohen, founder and co-CEO of Techstars, but he’s learned how to leverage his strengths and team to successfully raise the funds that power the Techstars network. In this episode, he shares his honest and authentic reflections from this experience.
I practice the principles of Conscious Leadership, a methodology and toolkit that accelerates self-awareness. It’s being taught at companies like Yahoo, Goldman Sachs and Ebay and has forever changed every aspect of my life. I estimate that it has bought me about five hours of extra time each day.
In this Fund81 podcast episode, I invited Brad Feld, founding partner of Foundry Group, to share his thoughts on maintaining mental health in the fast-paced venture capital world and supporting portfolio companies, colleagues, friends and family wrestling with mental health issues.
SC Moatti joined the Fund81 podcast to talk about how to discover and vet products in venture capital. We talk about how VCs can spot indications of future product success, creative ways to look under the hood before investing, and the product-related questions most venture capitalists fail to ask.